Inositol trisphosphate and diacylglycerol as intracellular second messengers in liver

Am J Physiol. 1985 Mar;248(3 Pt 1):C203-16. doi: 10.1152/ajpcell.1985.248.3.C203.

Abstract

Receptor occupation by a variety of Ca2+-mobilizing hormones, such as alpha 1-adrenergic agents, vasopressin and angiotensin II, causes a rapid phosphodiesterase-mediated hydrolysis of phosphatidylinositol-4,5-bisphosphate in the plasma membrane with the production of the water soluble compound myo-inositol-1,4,5-trisphosphate (IP3) and the lipophilic molecule 1,2-diacylglycerol (DG). This review summarizes the recent evidence obtained in the liver that defines the roles of these products as intracellular messengers of hormone action. Intracellular Ca2+ mobilization is mediated by IP3, which releases Ca2+ from a subpopulation of the endoplasmic reticulum, resulting in a rapid increase of the cytosolic free Ca2+ concentration ( [Ca2+]i). Further effects of receptor occupancy are inhibition of the plasma membrane Ca2+-ATPase, despite net Ca2+ efflux, and an increased permeability of the plasma membrane to extracellular Ca2+. The activation of the phospholipid-dependent protein kinase C by DG does not alter Ca2+ fluxes across the plasma membrane. In contrast to some secretory cells, a synergism between protein kinase C activation and increased [Ca2+]i is not observed in liver. Activation of protein kinase C profoundly inhibits the response to alpha 1-adrenergic agonists, with only minimal effects on the vasopressin response. It is concluded that in liver the two inositol-lipid messenger systems, IP3 and DG, exert their effects by essentially separate pathways.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Angiotensin II / pharmacology
  • Animals
  • Calcium / metabolism
  • Calcium / physiology
  • Cell Communication*
  • Cell Membrane / metabolism
  • Cell Membrane Permeability / drug effects
  • Diglycerides / metabolism
  • Diglycerides / pharmacology*
  • Endoplasmic Reticulum / metabolism
  • Glycerides / pharmacology*
  • Humans
  • Inositol 1,4,5-Trisphosphate
  • Inositol Phosphates / metabolism
  • Inositol Phosphates / pharmacology*
  • Ion Channels / metabolism
  • Liver / metabolism*
  • Mitochondria, Liver / metabolism
  • Phenylephrine / pharmacology
  • Protein Kinase C
  • Protein Kinases / metabolism
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / metabolism
  • Stimulation, Chemical
  • Sugar Phosphates / pharmacology*
  • Vasopressins / pharmacology

Substances

  • 1,2-diacylglycerol
  • Adrenergic alpha-Agonists
  • Diglycerides
  • Glycerides
  • Inositol Phosphates
  • Ion Channels
  • Receptors, Cell Surface
  • Sugar Phosphates
  • Vasopressins
  • Angiotensin II
  • Phenylephrine
  • Inositol 1,4,5-Trisphosphate
  • Protein Kinases
  • Protein Kinase C
  • Calcium